Lead Product(s) : Ninerafaxstat
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : University of Oxford
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 01, 2021
Lead Product(s) : Ninerafaxstat
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : University of Oxford
Deal Size : Inapplicable
Deal Type : Inapplicable